The first president of Johns Hopkins University, Daniel Coit Gilman, believed that teaching and research go hand in hand. He presumed that success in one depends on success in the other. He also believed that sharing knowledge and discoveries would help make the world a better place.
That's why our team was very pleased to visit Johns Hopkins Medicine to introduce the clinic to our new technology in tubal patency testing for women with known or suspected infertility. This Foam procedure offers a less complicated, less invasive alternative to the gold standard for diagnosing tubal patency - laparoscopy.1
We are working tirelessly to visit and train new US facilities, virtually and, where possible, in-person. Don't hesitate to reach out for more information about ExEm® Foam ((air polymer-type A) intrauterine foam) and follow us on LinkedIn for the latest updates.
ExEm® Foam ((air polymer-type A) intrauterine foam), the only FDA-approved contrast agent for ultrasound tubal patency testing, is now available at select fertility clinics nationwide.
ExEm® Foam Inc. team visited NYU Langone Health to introduce new technology in tubal patency testing.
ExEm Foam Inc.